SINO BIOPHARM 01177.HK announced the first quarter results ended March 2021. The revenue increased 16.4% year on year to RMB7.243 billion. The net profit for this pharmaceutical company amounted to RMB1.913 billion, up 118.5%.
EPS was 10.19 fen. A quarterly dividend of HK2 cents was declared, flattish yearly.
The ex-date will be the same as the ex-date for dividend final 2020. This will make 2 times HK$0.02 per share on June 18, 2021.
| For Dividend Growth & Value Investors.|
Sign up & get the list of 25 highest yield Dividend Growth companies (incl P/E and EPS)
Yes for free, no spam, no BS